1 completed, 1 unknown, 1 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Eye Hemorrhage: new trials by email Literature Review of Eye Hemorrhage trials Research Report on Eye Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH Aflibercept, Endolaserless Vitrectomy - Proliferative Diabetic Retinopathy | Phase 1 / Phase 2 | Unknown | Southeast Retina Center, Georgia | 24 | 2016-06-01 | 2016-11-29 |
| Preoperative Bevacizumab for Vitreous Hemorrhage bevacizumab, pars plana vitrectomy - Diabetic Retinopathy, Vitreous Hemorrhage | Phase 1 / Phase 2 | Completed | University of Sao Paulo | 16 | 2007-11-01 | 2008-10-03 |
| Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD) vitrectomy with subretinal lucentis - Retinal Hemorrhage, Macular Degeneration | Phase 1 | Withdrawn | Corewell Health East | 2007-09-01 | 2016-08-08 |
Vitreous Hemorrhage (2) · Diabetic Retinopathy (1) · Hemorrhage (1) · Macular Degeneration (1) · Retinal Hemorrhage (1)
Eye Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Hemorrhage (2) · Retinal Diseases (2) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Endocrine System Diseases (1) · Retinal Degeneration (1) · Vascular Diseases (1)
Bevacizumab (1) · Intravitreal Injections (1) · Vitrectomy (1) · aflibercept (1)
Corewell Health East (1) · Southeast Retina Center, Georgia (1) · University of Sao Paulo (1)
United States (2) · Brazil (1)
Daniel R Lucena, MD (1) · Dennis M Marcus, MD (1) · Tarek Hassan, MD (1)